神経科学抗体・アッセイの世界市場 2020年

• 英文タイトル：Global Neuroscience Antibodies and Assays Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114655 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、神経科学抗体・アッセイの世界市場を調査対象にし、神経科学抗体・アッセイの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（消耗品、機器）、用途別分析（製薬・バイオテクノロジー企業、学術・研究機関、病院・診断センター）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Thermo Fisher、BioLegend、Merck、Abcam、Rockland Immunochemicals、Bio-Rad、Roche、Genscript、Cell Signaling Technology、Santa Cruz Biotechnology、Siemens ・企業別売上、市場シェア ・神経科学抗体・アッセイの地域別市場分析 ・神経科学抗体・アッセイの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・神経科学抗体・アッセイのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・神経科学抗体・アッセイのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・神経科学抗体・アッセイの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・神経科学抗体・アッセイの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・神経科学抗体・アッセイの種類別市場規模2015-2020：消耗品、機器 ・神経科学抗体・アッセイの用途別市場規模2015-2020：製薬・バイオテクノロジー企業、学術・研究機関、病院・診断センター ・神経科学抗体・アッセイの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Neuroscience Antibodies and Assays market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 2991.2 million by 2025, from USD 2411.4 million in 2019.

The Neuroscience Antibodies and Assays market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Neuroscience Antibodies and Assays market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Neuroscience Antibodies and Assays market has been segmented into:
Consumables
Instruments

By Application, Neuroscience Antibodies and Assays has been segmented into:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuroscience Antibodies and Assays market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuroscience Antibodies and Assays markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuroscience Antibodies and Assays market.

The report offers in-depth assessment of the growth and other aspects of the Neuroscience Antibodies and Assays market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Neuroscience Antibodies and Assays Market Share Analysis
Neuroscience Antibodies and Assays competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuroscience Antibodies and Assays sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuroscience Antibodies and Assays sales, revenue and market share for each player covered in this report.

The major players covered in Neuroscience Antibodies and Assays are:
Thermo Fisher
BioLegend
Merck
Abcam
Rockland Immunochemicals
Bio-Rad
Roche
Genscript
Cell Signaling Technology
Santa Cruz Biotechnology
Siemens

レポート目次

---

Table of Contents

1 Neuroscience Antibodies and Assays Market Overview
1.1 Product Overview and Scope of Neuroscience Antibodies and Assays
1.2 Classification of Neuroscience Antibodies and Assays by Type
1.2.1 Global Neuroscience Antibodies and Assays Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Type in 2019
1.2.3 Consumables
1.2.4 Instruments
1.3 Global Neuroscience Antibodies and Assays Market by Application
1.3.1 Overview: Global Neuroscience Antibodies and Assays Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Hospitals & Diagnostic Centers
1.4 Global Neuroscience Antibodies and Assays Market by Regions
1.4.1 Global Neuroscience Antibodies and Assays Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Neuroscience Antibodies and Assays (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Neuroscience Antibodies and Assays Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Neuroscience Antibodies and Assays Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroscience Antibodies and Assays Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Neuroscience Antibodies and Assays Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroscience Antibodies and Assays Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher SWOT Analysis
2.1.4 Thermo Fisher Product and Services
2.1.5 Thermo Fisher Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioLegend
2.2.1 BioLegend Details
2.2.2 BioLegend Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BioLegend SWOT Analysis
2.2.4 BioLegend Product and Services
2.2.5 BioLegend Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abcam
2.4.1 Abcam Details
2.4.2 Abcam Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abcam SWOT Analysis
2.4.4 Abcam Product and Services
2.4.5 Abcam Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.5 Rockland Immunochemicals
2.5.1 Rockland Immunochemicals Details
2.5.2 Rockland Immunochemicals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Rockland Immunochemicals SWOT Analysis
2.5.4 Rockland Immunochemicals Product and Services
2.5.5 Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Rad SWOT Analysis
2.6.4 Bio-Rad Product and Services
2.6.5 Bio-Rad Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Roche SWOT Analysis
2.7.4 Roche Product and Services
2.7.5 Roche Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genscript
2.8.1 Genscript Details
2.8.2 Genscript Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genscript SWOT Analysis
2.8.4 Genscript Product and Services
2.8.5 Genscript Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cell Signaling Technology
2.9.1 Cell Signaling Technology Details
2.9.2 Cell Signaling Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cell Signaling Technology SWOT Analysis
2.9.4 Cell Signaling Technology Product and Services
2.9.5 Cell Signaling Technology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.10 Santa Cruz Biotechnology
2.10.1 Santa Cruz Biotechnology Details
2.10.2 Santa Cruz Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Santa Cruz Biotechnology SWOT Analysis
2.10.4 Santa Cruz Biotechnology Product and Services
2.10.5 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
2.11 Siemens
2.11.1 Siemens Details
2.11.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Siemens SWOT Analysis
2.11.4 Siemens Product and Services
2.11.5 Siemens Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Neuroscience Antibodies and Assays Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroscience Antibodies and Assays Players Market Share
3.2.2 Top 10 Neuroscience Antibodies and Assays Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Neuroscience Antibodies and Assays Revenue and Market Share by Regions
4.2 North America Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
4.3 Europe Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
4.5 South America Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
5 North America Neuroscience Antibodies and Assays Revenue by Countries
5.1 North America Neuroscience Antibodies and Assays Revenue by Countries (2015-2020)
5.2 USA Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
5.3 Canada Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
5.4 Mexico Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
6 Europe Neuroscience Antibodies and Assays Revenue by Countries
6.1 Europe Neuroscience Antibodies and Assays Revenue by Countries (2015-2020)
6.2 Germany Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
6.3 UK Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
6.4 France Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
6.5 Russia Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
6.6 Italy Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Neuroscience Antibodies and Assays Revenue by Countries
7.1 Asia-Pacific Neuroscience Antibodies and Assays Revenue by Countries (2015-2020)
7.2 China Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
7.3 Japan Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
7.4 Korea Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
7.5 India Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
8 South America Neuroscience Antibodies and Assays Revenue by Countries
8.1 South America Neuroscience Antibodies and Assays Revenue by Countries (2015-2020)
8.2 Brazil Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
8.3 Argentina Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Neuroscience Antibodies and Assays by Countries
9.1 Middle East & Africa Neuroscience Antibodies and Assays Revenue by Countries (2015-2020)
9.2 Saudi Arabia Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
9.3 UAE Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
9.4 Egypt Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
9.5 South Africa Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Neuroscience Antibodies and Assays Revenue and Market Share by Type (2015-2020)
10.2 Global Neuroscience Antibodies and Assays Market Forecast by Type (2019-2024)
10.3 Consumables Revenue Growth Rate (2015-2025)
10.4 Instruments Revenue Growth Rate (2015-2025)
11 Global Neuroscience Antibodies and Assays Market Segment by Application
11.1 Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2015-2020)
11.2 Neuroscience Antibodies and Assays Market Forecast by Application (2019-2024)
11.3 Pharmaceutical & Biotechnology Companies Revenue Growth (2015-2020)
11.4 Academic & Research Institutes Revenue Growth (2015-2020)
11.5 Hospitals & Diagnostic Centers Revenue Growth (2015-2020)
12 Global Neuroscience Antibodies and Assays Market Size Forecast (2021-2025)
12.1 Global Neuroscience Antibodies and Assays Market Size Forecast (2021-2025)
12.2 Global Neuroscience Antibodies and Assays Market Forecast by Regions (2021-2025)
12.3 North America Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
12.4 Europe Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
12.6 South America Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Neuroscience Antibodies and Assays Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuroscience Antibodies and Assays by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuroscience Antibodies and Assays Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Neuroscience Antibodies and Assays Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Corporate Information, Location and Competitors
Table 6. Thermo Fisher Neuroscience Antibodies and Assays Major Business
Table 7. Thermo Fisher Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher SWOT Analysis
Table 9. Thermo Fisher Neuroscience Antibodies and Assays Product and Solutions
Table 10. Thermo Fisher Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. BioLegend Corporate Information, Location and Competitors
Table 12. BioLegend Neuroscience Antibodies and Assays Major Business
Table 13. BioLegend Neuroscience Antibodies and Assays Total Revenue (USD Million) (2018-2019)
Table 14. BioLegend SWOT Analysis
Table 15. BioLegend Neuroscience Antibodies and Assays Product and Solutions
Table 16. BioLegend Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Neuroscience Antibodies and Assays Major Business
Table 19. Merck Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Neuroscience Antibodies and Assays Product and Solutions
Table 22. Merck Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abcam Corporate Information, Location and Competitors
Table 24. Abcam Neuroscience Antibodies and Assays Major Business
Table 25. Abcam Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 26. Abcam SWOT Analysis
Table 27. Abcam Neuroscience Antibodies and Assays Product and Solutions
Table 28. Abcam Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Rockland Immunochemicals Corporate Information, Location and Competitors
Table 30. Rockland Immunochemicals Neuroscience Antibodies and Assays Major Business
Table 31. Rockland Immunochemicals Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 32. Rockland Immunochemicals SWOT Analysis
Table 33. Rockland Immunochemicals Neuroscience Antibodies and Assays Product and Solutions
Table 34. Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bio-Rad Corporate Information, Location and Competitors
Table 36. Bio-Rad Neuroscience Antibodies and Assays Major Business
Table 37. Bio-Rad Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 38. Bio-Rad SWOT Analysis
Table 39. Bio-Rad Neuroscience Antibodies and Assays Product and Solutions
Table 40. Bio-Rad Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Roche Corporate Information, Location and Competitors
Table 42. Roche Neuroscience Antibodies and Assays Major Business
Table 43. Roche Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 44. Roche SWOT Analysis
Table 45. Roche Neuroscience Antibodies and Assays Product and Solutions
Table 46. Roche Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Genscript Corporate Information, Location and Competitors
Table 48. Genscript Neuroscience Antibodies and Assays Major Business
Table 49. Genscript Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 50. Genscript SWOT Analysis
Table 51. Genscript Neuroscience Antibodies and Assays Product and Solutions
Table 52. Genscript Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Cell Signaling Technology Corporate Information, Location and Competitors
Table 54. Cell Signaling Technology Neuroscience Antibodies and Assays Major Business
Table 55. Cell Signaling Technology Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 56. Cell Signaling Technology SWOT Analysis
Table 57. Cell Signaling Technology Neuroscience Antibodies and Assays Product and Solutions
Table 58. Cell Signaling Technology Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Santa Cruz Biotechnology Corporate Information, Location and Competitors
Table 60. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Major Business
Table 61. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 62. Santa Cruz Biotechnology SWOT Analysis
Table 63. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product and Solutions
Table 64. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Siemens Corporate Information, Location and Competitors
Table 66. Siemens Neuroscience Antibodies and Assays Major Business
Table 67. Siemens Neuroscience Antibodies and Assays Total Revenue (USD Million) (2017-2018)
Table 68. Siemens SWOT Analysis
Table 69. Siemens Neuroscience Antibodies and Assays Product and Solutions
Table 70. Siemens Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Neuroscience Antibodies and Assays Revenue (Million USD) by Players (2015-2020)
Table 72. Global Neuroscience Antibodies and Assays Revenue Share by Players (2015-2020)
Table 73. Global Neuroscience Antibodies and Assays Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Neuroscience Antibodies and Assays Revenue Market Share by Regions (2015-2020)
Table 75. North America Neuroscience Antibodies and Assays Revenue by Countries (2015-2020)
Table 76. North America Neuroscience Antibodies and Assays Revenue Market Share by Countries (2015-2020)
Table 77. Europe Neuroscience Antibodies and Assays Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Neuroscience Antibodies and Assays Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Neuroscience Antibodies and Assays Revenue by Countries (2015-2020)
Table 80. South America Neuroscience Antibodies and Assays Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Neuroscience Antibodies and Assays Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Neuroscience Antibodies and Assays Revenue Market Share by Countries (2015-2020)
Table 83. Global Neuroscience Antibodies and Assays Revenue (Million USD) by Type (2015-2020)
Table 84. Global Neuroscience Antibodies and Assays Revenue Share by Type (2015-2020)
Table 85. Global Neuroscience Antibodies and Assays Revenue Forecast by Type (2021-2025)
Table 86. Global Neuroscience Antibodies and Assays Revenue by Application (2015-2020)
Table 87. Global Neuroscience Antibodies and Assays Revenue Share by Application (2015-2020)
Table 88. Global Neuroscience Antibodies and Assays Revenue Forecast by Application (2021-2025)
Table 89. Global Neuroscience Antibodies and Assays Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Neuroscience Antibodies and Assays Picture
Figure 2. Global Neuroscience Antibodies and Assays Revenue Market Share by Type in 2019
Figure 3. Consumables Picture
Figure 4. Instruments Picture
Figure 5. Neuroscience Antibodies and Assays Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical & Biotechnology Companies Picture
Figure 7. Academic & Research Institutes Picture
Figure 8. Hospitals & Diagnostic Centers Picture
Figure 9. Global Neuroscience Antibodies and Assays Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Neuroscience Antibodies and Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Neuroscience Antibodies and Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Neuroscience Antibodies and Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Neuroscience Antibodies and Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Neuroscience Antibodies and Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Neuroscience Antibodies and Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Neuroscience Antibodies and Assays Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Neuroscience Antibodies and Assays Revenue Market Share in 2019
Figure 18. Global Top 10 Players Neuroscience Antibodies and Assays Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Neuroscience Antibodies and Assays Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Neuroscience Antibodies and Assays Revenue Market Share by Regions (2015-2020)
Figure 22. Global Neuroscience Antibodies and Assays Revenue Market Share by Regions in 2018
Figure 23. North America Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 24. Europe Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 26. South America Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 28. North America Neuroscience Antibodies and Assays Revenue Market Share by Countries (2015-2020)
Figure 29. North America Neuroscience Antibodies and Assays Revenue Market Share by Countries in 2019
Figure 30. USA Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 31. Canada Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 33. Europe Neuroscience Antibodies and Assays Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Neuroscience Antibodies and Assays Revenue Market Share by Countries in 2019
Figure 35. Germany Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 36. UK Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 37. France Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 38. Russia Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 39. Italy Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Neuroscience Antibodies and Assays Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Neuroscience Antibodies and Assays Revenue Market Share by Countries in 2019
Figure 42. China Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 43. Japan Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 44. Korea Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 45. India Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 47. South America Neuroscience Antibodies and Assays Revenue Market Share by Countries (2015-2020)
Figure 48. South America Neuroscience Antibodies and Assays Revenue Market Share by Countries in 2019
Figure 49. Brazil Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Neuroscience Antibodies and Assays Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Neuroscience Antibodies and Assays Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 54. UAE Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Neuroscience Antibodies and Assays Revenue and Growth Rate (2015-2020)
Figure 57. Global Neuroscience Antibodies and Assays Revenue Share by Type (2015-2020)
Figure 58. Global Neuroscience Antibodies and Assays Revenue Share by Type in 2019
Figure 59. Global Neuroscience Antibodies and Assays Market Share Forecast by Type (2021-2025)
Figure 60. Global Consumables Revenue Growth Rate (2015-2020)
Figure 61. Global Instruments Revenue Growth Rate (2015-2020)
Figure 62. Global Neuroscience Antibodies and Assays Revenue Share by Application (2015-2020)
Figure 63. Global Neuroscience Antibodies and Assays Revenue Share by Application in 2019
Figure 64. Global Neuroscience Antibodies and Assays Market Share Forecast by Application (2021-2025)
Figure 65. Global Pharmaceutical & Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 66. Global Academic & Research Institutes Revenue Growth Rate (2015-2020)
Figure 67. Global Hospitals & Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 68. Global Neuroscience Antibodies and Assays Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Neuroscience Antibodies and Assays Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Neuroscience Antibodies and Assays Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
Figure 72. Europe Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
Figure 74. South America Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Neuroscience Antibodies and Assays Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---